| Biotechnology Industry | Healthcare Sector | Christopher Jackson CEO | OTC PINK Exchange | 258484104 CUSIP |
| CA Country | - Employees | - Last Dividend | 16 Feb 2024 Last Split | - IPO Date |
Doseology Sciences Inc. is a Canadian company focused on the cultivation and extraction of nutraceutical and pharmaceutical products. Established in 2019 and headquartered in Kelowna, Canada, Doseology emphasizes the research, development, and commercialization of medicinal mushroom products, utilizing both online platforms and innovative product development to reach its customers. The company prides itself on advancing the field of medicinal mushrooms through rigorous scientific practices and aims to contribute positively to the health and wellbeing of its customers by providing high-quality, research-backed products.
Doseology Sciences Inc. produces a range of mushroom-based tinctures designed to offer various health benefits. These tinctures are created using precise extraction methods to ensure the high bioavailability of the active compounds, aiming to support wellness in areas such as immune health, mental clarity, and energy levels.
Along with tinctures, the company also offers powdered forms of its medicinal mushroom products. These powders are versatile and can be incorporated into a variety of daily routines, such as adding them to smoothies, coffee, or tea. They are designed to provide a convenient and effective way to integrate the health benefits of medicinal mushrooms into one’s diet.